K-numberK250637
Device nameVCFix Spinal System
ApplicantAmber Implants
Product codeNDN
Device classClass II
Decision dateMay 30, 2025
DecisionSubstantially Equivalent
Regulation888.3027
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The VCFix Spinal System is a cannulated, screw-shaped titanium implant with an expandable plate structure used to treat vertebral compression fractures from osteoporosis, trauma, or malignant lesions in the thoracic and lumbar spine (T9–L5). A pair of implants are inserted through the pedicles via a minimally invasive approach, expanded to restore vertebral height, and then stabilized with injected PMMA bone cement (Teknimed F20).

Technological characteristics

The VCFix is a titanium alloy (Ti-6Al-4V) cannulated implant available in 7 sizes (5–6.5 mm insertion diameter, 41–51.2 mm length) with perforated expansion plates and a jack mechanism for cranio-caudal expansion. It differs from the SpineJack predicate mainly in geometric details (perforated versus cut-through features) and implant sizing, but operates on the same principles of bilateral transpedicular insertion, in-situ expansion, and cement fixation with optional posterior instrumentation.

Test standards cited

ASTM F2077 (static and dynamic compression and shear), ASTM F2193 (static torsion and screw driving torque), ISO 10093-1 (biological safety evaluation), lift force testing, functionality testing with cement, magnetic resonance safety testing, and packaging, sterility, and shelf-life validation.

Substantial equivalence argument

The VCFix and SpineJack predicate share identical indications for use, target population, anatomical site, surgical approach, and operational principle (minimally invasive transpedicular insertion, in-situ expansion, cement fixation). Although the VCFix has minor geometric differences (perforated plates, 7 versus 3 sizes), these features fall within the dimensional range of previously cleared devices and are supported by equivalent mechanical and functional testing. No new safety or effectiveness risks are raised by these design variations, making the systems substantially equivalent in their fundamental technology and performance for treating thoracolumbar compression fractures.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →